|
|
Showing 1 - 6 of
6 matches in All Departments
Office-Based Infertility Practice is an invaluable resource to all physicians treating infertile couples. The text emphasizes the practice of infertility in the office setting, reflecting the current trend away from the hospital into the outpatient environment. The most current and advanced therapies available are discussed by recognized experts in the field. The first half of the book is devoted to the evaluation and work-up of the infertile couple, including evaluation of the male, female, age-related infertility factors, and the roles of ultrasound, endometrium saline sonography, falloposcopy and diagnostic laparoscopy and hysteroscopy. The second half of the book presents the treatment and operative procedures for the infertile couple, including ovulation induction, IUI, tubal cannulation, treatment of cervical stenosis, the use of office laparoscopy and therapeutic hysteroscopy, male treatment as support for IVF, vas reversals, and testicular biopsy, as well as routine IVF, intratubal gamete transfer, and micromanipulation. With over 60 illustrations, this book is a must for all infertility specialists, obstetrician-gynecologists, fellows, and residents. Its practical, comprehensive approach will be of daily use to the office practitioner treating women of reproductive age.
The practice of clinical reproductive medicine has practice in the
era of managed care and coordinat gradually moved from its initial
1980-90 hospital ing ancillary offsite medical personnel. base to
its present (circa 2001) office site of oper The objective of this
text is to assist in this ongo ation. With this transition have
been improvements ing endeavor by presenting in a clear, concise
man in efficiency of practice often in response to ner many of the
topics relevant to contemporary increased pressure to provide the
most patient sat office-based infertility practice. The initial
half of isfaction. An added challenge of office-based prac this
text addresses topics which focus upon general tice has been taking
on many of the responsibili concepts of infertility evaluation and
practice. The ties of what had been traditionally the hospital's
latter half is a practical approach to the execution domain. Some
of these new responsibilities have of specific office-based
infertility procedures. We included the ordering of operative
supplies and hope this book will assist all medical personnel who
equipment, the establishment of quality control dedicate their
clinical effort in achieving what is programs, construction and
maintenance of special most coveted by our patients, the birth of a
healthy laboratory spaces, redesigning efficient methods of
newborn. DAVID B. SEIFER, M. D. UMDNJ-Robert Wood Johnson Medical
School ROBERT L. COLLINS, M. D. The Reproductive Center,
Youngstown, Ohio October 2001 vii Contents Preface . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . vii . . . . . . . . . . . . . . . . . Contributors . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . xi . . . . . . . . . . . . . . . . . 1 Evaluation
of the Female for Infertility . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . 1 Bryan D."
Leading researchers and experienced clinicians join forces not only
to illuminate today's understanding of the endocrinology of
menopause, but also to provide a sound basis for its successful
management. These seasoned experts review in detail the
cardiovascular, bone, brain, and genitourinary changes that
accompany menopause and spell out the risks, benefits, and
alternatives of conventional hormone replacement therapy. Selective
estrogen receptor modulators (SERMs), androgen replacement, calcium
supplementation, and the role of phytoestrogens are also fully
reviewed. Menopause: Endocrinology and Management offers practicing
physicians a comprehensive understanding of the menopause process,
as well as an evidence-based approach to optimizing treatment
strategies for the challenging medical problems accompanying this
important period in women's lives.
Reproductive aging is a natural and universal process. Women
frequently overestimate the age at which a significant decline in
fertility occurs as well as overestimate the success of assisted
reproductive technologies to circumvent age-related infertility.
Yet there is much that modern medicine can do to improve conception
rates in women who delay childbearing and to manage subsequent
pregnancies. This book offers guidance on winning strategies for
maximizing the live-birth rate and limiting the risk for women
trying to conceive later in life. It is intended to assist in
navigating this challenging journey and lead to peace of mind that
women have been seen, heard, and treated as individuals in the
process. Written by leading experts addressing medical options of
applying advanced reproductive technologies, psychological,
nutritional, lifestyle, systematic approaches to optimizing
fertility care for the most challenging demographic of women in a
practical, clinically orientated, and most importantly, positive
way.
Now in a completely newly revised and expanded second edition, this
comprehensive text presents the current state of the art in our
understanding and management of polycystic ovary syndrome (PCOS),
the most common hormonal disorder of reproductive aged women. The
numerous bothersome symptoms of PCOS include menstrual
irregularities, hirsutism, acne, scalp hair thinning, weigh excess
and infertility; additionally, as they age, women with PCOS are at
a higher risk for metabolic abnormalities such as diabetes and
dyslipidemias, as well as for cardiovascular disease and even
certain cancers. Despite improvements in our understanding of this
condition, the exact cause/s of PCOS remain elusive; genetic,
hormonal, metabolic and environmental underpinnings are all
suggested as relevant. All chapters have been updated, with eight
new chapters added across seven thematic sections. Part one
discusses the epidemiology of PCOS in both adults and adolescents.
Part two covers the pathophysiology of PCOS, including genetics,
the hypothalamo-pituitary-ovarian and the
hypothalamo-pituitary-adrenal axes, insulin resistance,
inflammation, and obesity. The next three sections present the
various management strategies, medical and surgical, for harnessing
the symptomatology, including PCOS-related infertility; these
chapters include added case material to provide real-world examples
of the treatments in action and their efficacy. Part six covers the
comorbidities that women with PCOS commonly encounter, such as
issues of mental health, sleep disturbances, endometrial
hyperplasia, and cancer, as well as examines the economic burden of
PCOS. The final section discusses emerging concepts surrounding
possible mechanisms and potential therapeutic approaches to PCOS,
including angiogenic dysfunction, the role of vitamin D, future
potential therapies to targeted AMH signaling. The closing chapter,
by familiarizing the readers with the intergenerational
implications of PCOS and by raising awareness of potential "ripple
effects", aims at alerting the community on a need for vigilance as
regards the health of PCOS progeny. With contributions from leaders
in the field, Polycystic Ovary Syndrome, Second Edition remains the
gold-standard text on this common medical condition and a valuable
resource for the wide range of healthcare professionals engaged in
caring for the women with PCOS (including but not limited to
reproductive endocrinologists, gynecologists, family physicians,
dermatologists, mental health professionals), for the aspiring
women's health providers of tomorrow, and for the researchers who
are striving to unravel the mysteries of the complex entity that
PCOS is.
This is the first book published that discusses state of the art
research regarding AMH in human reproduction and medicine. This
unique and vital protein impacts a variety of fundamental processes
within the ovaries and testes. Since its discovery in 1947, every
medical student has learned about the role AMH plays in embryonic
sexual differentiation. However, the last fifteen years have
witnessed AMH emerge from the bench to the bedside, from a
scientific curiosity to a useful diagnostic tool with clinical
utility and therapeutic applications. In female reproduction, AMH
has undergone a virtual renaissance after it was discovered in the
human ovarian follicle and later to reflect ovarian reserve. Since
that time, much has been learned regarding the role of AMH in
female reproductive aging and a number of other gynecological
conditions. This is reflected by a number of peer-reviewed
publications on AMH in human adult females, which has increased
exponentially over the past three decades. It is only in the last
decade that AMH has become an important marker of ovarian response,
guiding clinical decision making in assisted reproductive
technology (ART) as well as a useful aid in the diagnosis of
polycystic ovarian syndrome (PCOS). In male reproduction, AMH has
become a diagnostic tool in the complex evaluation of infants with
intersex conditions, including ambiguous genitalia and
cryptorchidism. The chapters of this book bring together
experienced investigators with a variety of research interests in
different aspects of AMH. Each contributor has conducted clinical,
translational and/or basic research in the field of AMH. Each has
an appreciation of what is known and an aspiration for solving what
remains to be discovered. A better understanding of AMH
pathophysiology may lead to the development of pharmacological
treatments using AMH agonists and/or antagonists for a host of
reproductive challenges. These include: the possible retardation of
ovarian aging and menopause; a chemoprotectant for fertility
preservation prior to chemotherapy; a tool to better control
ovarian response to ART and/or to mitigate the deleterious effects
of polycystic ovary syndrome; and a treatment for endometriosis,
adenomyosis and/or endometrial and ovarian cancers. This book
enables the reader to review the past, understand the present and
consider the future of this multifaceted protein in the fields of
reproductive medicine and gynecology.
|
|